• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

库欣病的细胞周期调节因子和谱系特异性治疗靶点

Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease.

作者信息

Araki Takako, Liu Ning-Ai

机构信息

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.

Department of Medicine, Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

出版信息

Front Endocrinol (Lausanne). 2018 Aug 10;9:444. doi: 10.3389/fendo.2018.00444. eCollection 2018.

DOI:10.3389/fendo.2018.00444
PMID:30147673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6096271/
Abstract

Cell cycle proteins are critical to pituitary development, but their contribution to lineage-specific tumorigenesis has not been well-elucidated. Emerging evidence from human tumor analysis and transgenic mouse models indicates that G1/S-related cell cycle proteins, particularly cyclin E, p27, Rb, and E2F1, drive molecular mechanisms that underlie corticotroph-specific differentiation and development of Cushing disease. The aim of this review is to summarize the literature and discuss the complex role of cell cycle regulation in Cushing disease, with a focus on identifying potential targets for therapeutic intervention in patients with these tumors.

摘要

细胞周期蛋白对垂体发育至关重要,但其对谱系特异性肿瘤发生的作用尚未得到充分阐明。来自人类肿瘤分析和转基因小鼠模型的新证据表明,与G1/S相关的细胞周期蛋白,特别是细胞周期蛋白E、p27、视网膜母细胞瘤蛋白(Rb)和E2F1,驱动着促肾上腺皮质激素细胞特异性分化和库欣病发展的分子机制。这篇综述的目的是总结文献,并讨论细胞周期调控在库欣病中的复杂作用,重点是确定这些肿瘤患者治疗干预的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43ab/6096271/6476e57618cd/fendo-09-00444-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43ab/6096271/6476e57618cd/fendo-09-00444-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43ab/6096271/6476e57618cd/fendo-09-00444-g0001.jpg

相似文献

1
Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease.库欣病的细胞周期调节因子和谱系特异性治疗靶点
Front Endocrinol (Lausanne). 2018 Aug 10;9:444. doi: 10.3389/fendo.2018.00444. eCollection 2018.
2
Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.细胞周期蛋白E介导的阿黑皮素原调节作为库欣病的治疗靶点
J Clin Endocrinol Metab. 2015 Jul;100(7):2557-64. doi: 10.1210/jc.2015-1606. Epub 2015 May 5.
3
Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).9号染色体短臂缺失导致p16INK4A下调,并在胃肠道间质瘤(GISTs)中促进依赖RB/E2F1的细胞周期进程。
J Pathol. 2008 Jul;215(3):253-62. doi: 10.1002/path.2352.
4
Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.细胞周期抑制剂p27Kip1在正常促肾上腺皮质激素细胞、促肾上腺皮质激素肿瘤及恶性垂体肿瘤中低表达。
J Clin Endocrinol Metab. 1999 Oct;84(10):3823-30. doi: 10.1210/jcem.84.10.6066.
5
Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.促肾上腺皮质激素分泌肿瘤中p27/kip1基因的突变与表达分析
Oncogene. 1998 Jan 8;16(1):69-76. doi: 10.1038/sj.onc.1201516.
6
Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.转基因诱导膀胱肿瘤表型变体中细胞周期调节因子的差异表达:对肿瘤行为的影响。
Cancer Res. 2005 Feb 15;65(4):1150-7. doi: 10.1158/0008-5472.CAN-04-2074.
7
Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.磷酸化p27(Kip1)蛋白和Jun激活域结合蛋白1在人垂体肿瘤中的表达
J Clin Endocrinol Metab. 2002 Jun;87(6):2635-43. doi: 10.1210/jcem.87.6.8517.
8
Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.细胞周期蛋白D2和p27是抑制素α基因敲除小鼠肿瘤发生的组织特异性调节因子。
Mol Endocrinol. 2003 Oct;17(10):2053-69. doi: 10.1210/me.2003-0038. Epub 2003 Jul 10.
9
Aberrant expression of the Rb pathway proteins in soft tissue sarcomas.软组织肉瘤中Rb通路蛋白的异常表达。
Appl Immunohistochem Mol Morphol. 2006 Dec;14(4):397-403. doi: 10.1097/01.pai.0000190176.06200.68.
10
Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.胃肠道间质瘤中细胞周期调节蛋白的表达改变:具有潜在预后意义的标志物
Hum Pathol. 2006 Jun;37(6):648-55. doi: 10.1016/j.humpath.2006.01.023.

引用本文的文献

1
PinX1 plays multifaceted roles in human cancers: a review and perspectives.PinX1 在人类癌症中发挥多方面作用:综述与展望。
Mol Biol Rep. 2024 Nov 17;51(1):1163. doi: 10.1007/s11033-024-10082-x.
2
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.神经调节素 B 受体作为促肾上腺皮质腺瘤的潜在治疗靶点。
Pituitary. 2023 Oct;26(5):597-610. doi: 10.1007/s11102-023-01350-3. Epub 2023 Aug 29.
3
The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages.

本文引用的文献

1
Pituitary-Directed Therapies for Cushing's Disease.库欣病的垂体定向治疗
Front Endocrinol (Lausanne). 2018 May 1;9:164. doi: 10.3389/fendo.2018.00164. eCollection 2018.
2
EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis.表皮生长因子受体(EGFR)诱导E2F1介导的促肾上腺皮质激素细胞肿瘤发生。
J Endocr Soc. 2017 Jan 20;1(2):127-143. doi: 10.1210/js.2016-1053. eCollection 2017 Feb 1.
3
Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease.体细胞USP8基因突变是儿童库欣病的常见病因。
垂体腺瘤的激酶组、细胞周期蛋白和细胞周期蛋白依赖性激酶,观察不同谱系肿瘤之间的基因表达谱。
BMC Med Genomics. 2022 Mar 8;15(1):52. doi: 10.1186/s12920-022-01206-y.
4
Recent Understanding and Future Directions of Recurrent Corticotroph Tumors.复发性促肾上腺皮质细胞瘤的最新认识与未来方向。
Front Endocrinol (Lausanne). 2021 Apr 26;12:657382. doi: 10.3389/fendo.2021.657382. eCollection 2021.
5
Cushing's Disease.库欣病
J Clin Med. 2019 Nov 12;8(11):1951. doi: 10.3390/jcm8111951.
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2836-2843. doi: 10.1210/jc.2017-00161.
4
E2F1-mediated human POMC expression in ectopic Cushing's syndrome.E2F1介导的异位库欣综合征中人类促肾上腺皮质激素原(POMC)的表达
Endocr Relat Cancer. 2016 Nov;23(11):857-870. doi: 10.1530/ERC-16-0206. Epub 2016 Oct 7.
5
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: DIAGNOSIS OF RECURRENCE IN CUSHING DISEASE.美国临床内分泌医师协会和美国内分泌学会疾病状态临床综述:库欣病复发的诊断
Endocr Pract. 2016 Dec;22(12):1436-1448. doi: 10.4158/EP161512.DSCR. Epub 2016 Sep 19.
6
Treating cancer with selective CDK4/6 inhibitors.用选择性 CDK4/6 抑制剂治疗癌症。
Nat Rev Clin Oncol. 2016 Jul;13(7):417-30. doi: 10.1038/nrclinonc.2016.26. Epub 2016 Mar 31.
7
The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.USP8 基因突变状态可能预测库欣病促肾上腺皮质激素腺瘤的药物敏感性。
Eur J Endocrinol. 2016 Feb;174(2):213-26. doi: 10.1530/EJE-15-0689. Epub 2015 Nov 17.
8
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.奥西卓司他,一种强效口服11β-羟化酶抑制剂:库欣病的22周前瞻性II期研究。
Pituitary. 2016 Apr;19(2):138-48. doi: 10.1007/s11102-015-0692-z.
9
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.甲吡酮治疗库欣综合征的有效性:一项针对195例患者的回顾性多中心研究
J Clin Endocrinol Metab. 2015 Nov;100(11):4146-54. doi: 10.1210/jc.2015-2616. Epub 2015 Sep 9.
10
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.库欣综合征的治疗:美国内分泌学会临床实践指南
J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29.